Early research (Phase 1)Study completedNCT02354534
What this trial is testing
Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2/3High-risk HPV (Any Strain)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30